Amplo Biotechnology
Amplo Biotechnology
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluating the Safety and Effects of AMP-101 in People With DOK7 Congenital Myasthenia Syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, congenital myasthenic syndrome, hereditary disease, nervous system disorder, neuromuscular disease, neuromuscular junction disease | Not yet recruiting | Phase 1 | 2026-09-21 | NCT07830563 |